Establishing Rigorous and Cost-effective Clinical Trials for Artificial Intelligence Models

• URL: http://arxiv.org/abs/2407.08554v2
• Date: Sun, 28 Jul 2024 15:33:33 GMT
• Title: Establishing Rigorous and Cost-effective Clinical Trials for Artificial Intelligence Models
• Authors: Wanling Gao, Yunyou Huang, Dandan Cui, Zhuoming Yu, Wenjing Liu, Xiaoshuang Liang, Jiahui Zhao, Jiyue Xie, Hao Li, Li Ma, Ning Ye, Yumiao Kang, Dingfeng Luo, Peng Pan, Wei Huang, Zhongmou Liu, Jizhong Hu, Gangyuan Zhao, Chongrong Jiang, Fan Huang, Tianyi Wei, Suqin Tang, Bingjie Xia, Zhifei Zhang, Jianfeng Zhan,
• Abstract summary: A profound gap persists between artificial intelligence (AI) and clinical practice in medicine. State-of-the-art and state-of-the-practice AI model evaluations are limited to laboratory studies on medical datasets or direct clinical trials with no or solely patient-centered controls. For the first time, we emphasize the critical necessity for rigorous and cost-effective evaluation methodologies for AI models in clinical practice.
• Score: 18.240773244542474
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: A profound gap persists between artificial intelligence (AI) and clinical practice in medicine, primarily due to the lack of rigorous and cost-effective evaluation methodologies. State-of-the-art and state-of-the-practice AI model evaluations are limited to laboratory studies on medical datasets or direct clinical trials with no or solely patient-centered controls. Moreover, the crucial role of clinicians in collaborating with AI, pivotal for determining its impact on clinical practice, is often overlooked. For the first time, we emphasize the critical necessity for rigorous and cost-effective evaluation methodologies for AI models in clinical practice, featuring patient/clinician-centered (dual-centered) AI randomized controlled trials (DC-AI RCTs) and virtual clinician-based in-silico trials (VC-MedAI) as an effective proxy for DC-AI RCTs. Leveraging 7500 diagnosis records from two-step inaugural DC-AI RCTs across 14 medical centers with 125 clinicians, our results demonstrate the necessity of DC-AI RCTs and the effectiveness of VC-MedAI. Notably, VC-MedAI performs comparably to human clinicians, replicating insights and conclusions from prospective DC-AI RCTs. We envision DC-AI RCTs and VC-MedAI as pivotal advancements, presenting innovative and transformative evaluation methodologies for AI models in clinical practice, offering a preclinical-like setting mirroring conventional medicine, and reshaping development paradigms in a cost-effective and fast-iterative manner. Chinese Clinical Trial Registration: ChiCTR2400086816.

Related papers

• Framework for developing and evaluating ethical collaboration between expert and machine [4.304304889487245]
  Precision medicine is a promising approach for accessible disease diagnosis and personalized intervention planning. By leveraging artificial intelligence (AI), precision medicine tailors diagnosis and treatment solutions to individual patients. However, the adoption of AI in medical applications faces significant challenges. This paper proposes a framework to develop and ethically evaluate expert-guided multi-modal AI.
  arXiv  Detail & Related papers  (2024-11-17T06:49:38Z)
• Clinical Evaluation of Medical Image Synthesis: A Case Study in Wireless Capsule Endoscopy [63.39037092484374]
  This study focuses on the clinical evaluation of medical Synthetic Data Generation using Artificial Intelligence (AI) models. The paper contributes by a) presenting a protocol for the systematic evaluation of synthetic images by medical experts and b) applying it to assess TIDE-II, a novel variational autoencoder-based model for high-resolution WCE image synthesis. The results show that TIDE-II generates clinically relevant WCE images, helping to address data scarcity and enhance diagnostic tools.
  arXiv  Detail & Related papers  (2024-10-31T19:48:50Z)
• AI in radiological imaging of soft-tissue and bone tumours: a systematic review evaluating against CLAIM and FUTURE-AI guidelines [1.5332408886895255]
  Soft-tissue and bone tumours (STBT) are rare, diagnostically challenging lesions with variable clinical behaviours and treatment approaches. This systematic review provides an overview of Artificial Intelligence (AI) methods using radiological imaging for diagnosis and prognosis of these tumours.
  arXiv  Detail & Related papers  (2024-08-22T15:31:48Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• TREEMENT: Interpretable Patient-Trial Matching via Personalized Dynamic Tree-Based Memory Network [54.332862955411656]
  Clinical trials are critical for drug development but often suffer from expensive and inefficient patient recruitment. In recent years, machine learning models have been proposed for speeding up patient recruitment via automatically matching patients with clinical trials. We introduce a dynamic tree-based memory network model named TREEMENT to provide accurate and interpretable patient trial matching.
  arXiv  Detail & Related papers  (2023-07-19T12:35:09Z)
• Evaluation of Popular XAI Applied to Clinical Prediction Models: Can They be Trusted? [2.0089256058364358]
  The absence of transparency and explainability hinders the clinical adoption of Machine learning (ML) algorithms. This study evaluates two popular XAI methods used for explaining predictive models in the healthcare context.
  arXiv  Detail & Related papers  (2023-06-21T02:29:30Z)
• A Transformer-based representation-learning model with unified processing of multimodal input for clinical diagnostics [63.106382317917344]
  We report a Transformer-based representation-learning model as a clinical diagnostic aid that processes multimodal input in a unified manner. The unified model outperformed an image-only model and non-unified multimodal diagnosis models in the identification of pulmonary diseases.
  arXiv  Detail & Related papers  (2023-06-01T16:23:47Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• OpenClinicalAI: enabling AI to diagnose diseases in real-world clinical settings [11.287929392365756]
  We build a clinical AI benchmark named Clinical AIBench to set up real-world clinical settings to facilitate researches. We propose an open, dynamic machine learning framework and develop an AI system named OpenClinicalAI to diagnose diseases in real-world clinical settings. In the real-world clinical setting, OpenClinicalAI significantly outperforms the state-of-the-art AI system.
  arXiv  Detail & Related papers  (2021-09-09T02:59:36Z)
• Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19 [71.41929762209328]
  The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world. Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19. The recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists.
  arXiv  Detail & Related papers  (2020-04-06T15:21:34Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.